Top compounds associated with response to RP11-571M6.15


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.081 0.02
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.079 0.02
mRNA Axitinib CTRPv2 pan-cancer AAC -0.076 0.02
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.097 0.02
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.077 0.02
mRNA indisulam CTRPv2 pan-cancer AAC -0.07 0.03
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.03
mRNA isoevodiamine CTRPv2 pan-cancer AAC -0.069 0.03
mRNA canertinib CTRPv2 pan-cancer AAC -0.077 0.03
Download CSV